Profile Picture
Rewards
  • Search
  • Chat
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
    • Real Estate
    • My Bing
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

Wins Heisman Trophy
10-year, $700M contract
UPenn president resigns
Storms rake Tennessee
To start new hunger strike
50s popular singer dies
Royal family Christmas card
Starts subscription website
Could be reinstated to X
Space-grown tomato found
Arrested on DUI charge
Sale of ammunition to Israel
Banned from the sideline
Lands in concussion protocol
Burrow injury investigation
Hospitalized in car accident
Jaguars sign Nathan Rourke
Houston's next mayor
Variety alum dies at 74
Bomb threat at drag brunch
White Sox acquire Stassi
3 killed in Atlanta shooting
Chevron-Hess merger probe
Hollywood fundraising tour
Emmy-nominated Rogow dies
'Historic' bid to regulate AI
Mason Crosby activated
To transfer to Oregon
Leads Biden in new '24 poll
Ruled out w/ knee injury
Army beats Navy 17-11
European Film Awards '23
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
5,580 results
2don MSN
White House might punish Big Pharma's high prices by removing patents
The Biden administration is flexing some federal muscle in its push for lower drug prices, warning pharmaceutical companies ...
Axios on MSN
1d
Drug negotiations could save seniors hundreds of dollars: study
Medicare negotiations of prescription drug prices could have cut seniors' out-of-pocket costs by nearly a quarter had the program been in effect in 2021, according to an analysis Mathematica provided ...
Opinion
2dOpinion
Opinion: Medicare’s drug price ‘negotiations’ are anything but
Controls on drug prices will stifle our ability to innovate while also damaging the economy, Alexandria economist Justin Vélez-Hagan, Ph.D., writes in a guest column.
FiercePharma
2d
As Biden administration eyes 'march-in' rights to lower drug prices, pharma gears up for battle
While so-called “march-in” rights have yet to materialize in the United States, the controversial measure to cut drug prices appears to be gaining traction with the government. | While so-called ...
OHE
10d
The Inflation Reduction Act: Price negotiation underway for the first 10 drugs
The first 10 drugs included in the Medicare Drug Price Negotiation Program created by the Inflation Reduction Act (IRA) were ...
JD Supra13d
Are Drugmakers Gaming the Patent System?
We all know that policymakers are increasingly focused on lowering drug costs. From the Inflation Reductions Act's Medicare price negotiations (aka price controls) to the recent proposals directed at ...
HealthLeaders Media
2d
Colorado Blames Biden Team and Drugmakers for Delaying Canadian Imports
Colorado officials say their plan to import cheaper medicines from Canada has been stymied by opposition from drugmakers and ...
9d
Why drugmakers are lobbying hard | Morning Newsletter
It was a huge defeat for Big Pharma when Congress and President Joe Biden enacted a law aimed in part at lowering ...
Health Affairs12d
Arriving At A Fair Price In The Medicare Drug Price Negotiation Program: Considerations From Other Countries
Under the Inflation Reduction Act (IRA) of 2022, the Centers for Medicare and Medicaid Services (CMS) will begin negotiating drug prices for a subset of drugs in Medicare. In doing so, CMS must ...
Roll Call22d
The inescapable ad campaign for a wonky drug policy debate
A smarmy executive is all over Washington these days, which is really nothing new. But this particular suit is everywhere. And according to the lobbying group behind the commercials he stars in ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices